title: Xerostomia in head and neck malignancy.
abstract: Xerostomia (dry mouth) as a consequence of treatment of head and neck malignancy is almost always due to radiotherapy. The resultant salivary gland dysfunction can adversely affect oral and systemic health as well as lessen quality of life. While the present management of radiotherapy-associated salivary dysfunction is challenging there have been striking advances in preventative strategies and a number of possible treatment options may be over the near horizon.
authors.affiliation: Oral Medicine and Special Needs Dentistry, UCL Eastman Dental Institute, 256 Grays Inn Road, London WC1X 8LD, United Kingdom. s.porter@eastman.ucl.ac.uk
authors.forename: S R
authors.initials: SR
authors.lastname: Porter
authors.forename: S
authors.initials: S
authors.lastname: Fedele
authors.forename: K M
authors.initials: KM
authors.lastname: Habbab
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D011788:Quality of Life; D011832:Radiation Injuries / Q000150:complications; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D012469:Salivary Glands / Q000528:radiation effects*; D014987:Xerostomia / Q000209:etiology* / Q000628:therapy